Schroder Investment Management Group Intra Cellular Therapies, Inc. Transaction History

Schroder Investment Management Group

  • $101 Billion
  • Q4 2024

A detailed history of Schroder Investment Management Group transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 743,230 shares of ITCI stock, worth $97.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
743,230
Previous 924,171 19.58%
Holding current value
$97.6 Million
Previous $67.6 Million 8.14%
% of portfolio
0.06%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$71.19 - $91.57 $12.9 Million - $16.6 Million
-180,941 Reduced 19.58%
743,230 $62.1 Million
Q3 2024

Nov 13, 2024
BUY
$67.99 - $80.84 $11.7 Million - $13.9 Million
172,281 Added 22.91%
924,171 $67.6 Million
Q2 2024

Aug 12, 2024
BUY
$64.76 - $79.84 $8.65 Million - $10.7 Million
133,502 Added 21.59%
751,890 $51.5 Million
Q1 2024

May 14, 2024
SELL
$64.37 - $75.65 $10.4 Million - $12.2 Million
-161,435 Reduced 20.7%
618,388 $42.8 Million
Q4 2023

Feb 13, 2024
BUY
$46.37 - $73.65 $9.71 Million - $15.4 Million
209,331 Added 36.69%
779,823 $55.9 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $7.78 Million - $9.58 Million
-149,419 Reduced 20.76%
570,492 $29.7 Million
Q2 2023

Aug 11, 2023
SELL
$54.67 - $66.44 $12.4 Million - $15 Million
-226,074 Reduced 23.9%
719,911 $45.6 Million
Q1 2023

May 11, 2023
BUY
$43.8 - $56.99 $3.59 Million - $4.67 Million
82,024 Added 9.49%
945,985 $51.2 Million
Q4 2022

Feb 10, 2023
SELL
$44.07 - $54.45 $598,294 - $739,213
-13,576 Reduced 1.55%
863,961 $45.7 Million
Q3 2022

Nov 10, 2022
BUY
$42.7 - $59.99 $1.58 Million - $2.22 Million
37,021 Added 4.4%
877,537 $40.8 Million
Q2 2022

Aug 11, 2022
SELL
$43.0 - $65.64 $6.17 Million - $9.41 Million
-143,397 Reduced 14.57%
840,516 $49 Million
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $7.59 Million - $12.2 Million
-195,926 Reduced 16.61%
983,913 $59.4 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $1.07 Million - $1.63 Million
30,498 Added 2.65%
1,179,839 $61.8 Million
Q3 2021

Nov 12, 2021
SELL
$28.72 - $42.49 $4.48 Million - $6.62 Million
-155,849 Reduced 11.94%
1,149,341 $42.8 Million
Q2 2021

Aug 13, 2021
SELL
$29.3 - $44.5 $521,715 - $792,367
-17,806 Reduced 1.35%
1,305,190 $53.3 Million
Q1 2021

May 17, 2021
BUY
$30.8 - $39.51 $307,076 - $393,914
9,970 Added 0.76%
1,322,996 $44.9 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $7.31 Million - $10.1 Million
313,129 Added 31.32%
1,313,026 $41.8 Million
Q3 2020

Nov 13, 2020
SELL
$17.61 - $31.86 $2.11 Million - $3.81 Million
-119,645 Reduced 10.69%
999,897 $23.8 Million
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $24,524 - $45,527
1,709 Added 0.15%
1,119,542 $28.7 Million
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $4.49 Million - $12.1 Million
364,938 Added 48.47%
1,117,833 $17.3 Million
Q4 2019

Feb 11, 2020
SELL
$7.26 - $38.49 $4.91 Million - $26 Million
-675,656 Reduced 47.3%
752,895 $25.8 Million
Q3 2019

Nov 12, 2019
SELL
$7.47 - $14.03 $14,327 - $26,909
-1,918 Reduced 0.13%
1,428,551 $10.7 Million
Q2 2019

Aug 08, 2019
BUY
$10.65 - $14.29 $806,812 - $1.08 Million
75,757 Added 5.59%
1,430,469 $18.6 Million
Q1 2019

May 14, 2019
BUY
$10.9 - $14.09 $2.15 Million - $2.78 Million
197,356 Added 17.05%
1,354,712 $16.5 Million
Q4 2018

Feb 14, 2019
SELL
$10.36 - $20.96 $451,178 - $912,808
-43,550 Reduced 3.63%
1,157,356 $13.2 Million
Q3 2018

Nov 13, 2018
BUY
$17.77 - $22.9 $129,934 - $167,444
7,312 Added 0.61%
1,200,906 $26.1 Million
Q2 2018

Aug 24, 2018
BUY
$17.33 - $23.4 $20.7 Million - $27.9 Million
1,193,594 New
1,193,594 $21.2 Million

Others Institutions Holding ITCI

# of Institutions
419
Shares Held
88.8M
Call Options Held
284K
Put Options Held
105K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email